Cargando…
The effect of three major co‐morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction
AIMS: Diabetes mellitus, chronic obstructive pulmonary disease, and chronic kidney disease are prevalent in patients with heart failure with reduced ejection fraction (HFrEF). We have analysed the impact of co‐morbidities on quality of life (QoL) and outcome. METHODS AND RESULTS: A total of 397 pati...
Autores principales: | Benes, Jan, Kotrc, Martin, Jarolim, Petr, Hoskova, Lenka, Hegarova, Marketa, Dorazilova, Zora, Podzimkova, Mariana, Binova, Jana, Lukasova, Marianna, Malek, Ivan, Franekova, Janka, Jabor, Antonin, Kautzner, Josef, Melenovsky, Vojtech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006738/ https://www.ncbi.nlm.nih.gov/pubmed/33512782 http://dx.doi.org/10.1002/ehf2.13227 |
Ejemplares similares
-
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
por: Benes, Jan, et al.
Publicado: (2022) -
B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle
por: Hegarova, Marketa, et al.
Publicado: (2016) -
Right ventricular global dysfunction score: a new concept of right ventricular function assessment in patients with heart failure with reduced ejection fraction (HFrEF)
por: Benes, Jan, et al.
Publicado: (2023) -
FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF
por: Benes, Jan, et al.
Publicado: (2023) -
Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure
por: Melenovsky, Vojtech, et al.
Publicado: (2017)